EDIT Q4 2022 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M-47.6% YoY

Gross Profit

-$45M-695.6% margin

Operating Income

-$63M-970.7% margin

Net Income

-$61M-929.3% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+15461.9%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$514M

Total Liabilities

$154M

Stockholders' Equity

$361M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$12M	-47.6%
Gross Profit	-$45M	-$25M	-81.2%
Operating Income	-$63M	-$42M	-52.5%
Net Income	-$61M	-$41M	-46.6%